Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 34

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 34
---
div>

The following description summarizes the material
terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important to you. For a
complete description of our capital stock, you should refer to our Third Amended and Restated Certificate of Incorporation and our Amended
and Restated Bylaws, each as amended from time to time, and to the provisions of applicable Delaware law.

Common Stock

Our common stock is traded on the Nasdaq Capital
Market under the symbol “DERM.”

The authorized capital stock of Journey consists
of 50,000,000 shares of common stock, with $0.0001 par value, 6,000,000 shares of which have been designated as Class A Common Stock,
and 5,000,000 shares of Preferred Stock, par value $0.0001 per share. The shares of Preferred Stock are undesignated.

Class A Common Stock

The description of our Class A Common Stock
in this item is for information purposes only. All of the Class A Common Stock has been issued to Fortress.

Class A Common Stock is identical to our
common stock other than as to voting rights and the election of directors for a definite period (as described below). On any matter presented
to our stockholders for their action or consideration at any meeting of our stockholders (or by written consent of stockholders in lieu
of meeting), each holder of outstanding shares of Class A Common Stock will be entitled to cast for each share of Class A Common
Stock held by such holder as of the record date for determining stockholders entitled to vote on such matter, the number of votes that
is equal to one and one-tenth (1.1) times a fraction, the numerator of which is the number of shares of outstanding common stock and the
denominator of which is the number of shares of outstanding Class A Common Stock (the “Class A Common Stock Ratio”).
Thus, the Class A Common Stock will at all times constitute a voting majority.

For a period of ten (10) years from the date
of the first issuance of shares of Class A Common Stock (the “Class A Director Period”), the holders of record of
the shares of Class A Common Stock (or other capital stock or securities issued upon conversion of or in exchange for the Class A
Common Stock), exclusively and as a separate class, shall be entitled to appoint or elect the majority of the directors of Journey (the
“Class A Directors”).